Last 26 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -3.43 | 25.76 | 1.10 | — | — | — | 36.08 | — | — | — | — | — | — | — | 148.44 | — | — | — | 2185.34 | — | — |
| — | — | -97.0% | — | — | — | — | — | — | — | — | — | — | — | -93.2% | — | — | — | — | — | — | |
| P/S Ratio | 0.24 | 0.31 | 0.02 | 0.05 | 0.07 | 0.17 | 0.29 | 0.13 | 0.28 | 0.45 | 0.39 | 1.57 | 1.58 | 1.66 | 2.40 | 2.41 | 3.46 | 3.32 | 4.11 | 5.78 | 5.59 |
| — | +80.9% | -92.0% | -64.6% | -73.3% | -62.4% | -25.0% | -91.8% | -82.4% | -72.7% | -83.8% | -34.7% | -54.2% | -49.8% | -41.6% | -58.3% | -38.0% | -56.8% | — | — | — | |
| P/B Ratio | 10.99 | 8.11 | 0.73 | 2.25 | 1.39 | 2.33 | 3.57 | 1.66 | 2.81 | 3.98 | 3.62 | 7.76 | 8.27 | 8.09 | 9.36 | 6.39 | 8.87 | 8.06 | 9.67 | 9.80 | 9.10 |
| — | +248.4% | -79.7% | +35.6% | -50.4% | -41.5% | -1.4% | -78.6% | -66.0% | -50.8% | -61.3% | +21.5% | -6.8% | +0.4% | -3.2% | -34.8% | -2.5% | -39.5% | — | — | — | |
| P/FCF | — | — | 1.60 | — | — | — | — | 48.98 | 60.76 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 23.76 | 0.37 | — | — | — | — | — | — | — | — | — | — | — | 531.37 | — | — | — | 930.01 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | -42.9% | — | — | — | — | — | — | |
| EV / EBIT | — | 101.77 | 0.22 | — | — | — | — | — | — | — | 137.79 | — | — | — | 252.71 | — | — | — | 1602.84 | — | — |
| — | — | — | — | — | — | — | — | — | — | -45.5% | — | — | — | -84.2% | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -3.2% | 7.2% | 4.1% | -6.2% | -4.7% | -3.8% | 3.3% | -2.5% | -4.4% | 2.2% | 4.7% | -11.7% | 3.2% | 5.1% | 6.9% | 1.4% | 3.7% | 5.1% | 6.5% | 2.1% | 3.3% |
| — | +290.7% | +23.9% | -147.6% | -6.6% | -273.2% | -29.3% | +78.5% | -236.5% | -57.5% | -32.5% | -906.3% | -13.1% | +0.9% | +6.7% | -30.0% | +14.3% | +10.9% | -7.7% | +25.8% | -59.9% | |
| Operating Margin | -7.1% | 0.8% | 0.7% | -9.9% | -9.1% | -8.3% | -1.4% | -7.1% | -9.2% | -2.9% | -0.4% | -19.6% | -3.5% | -2.7% | 0.0% | -10.0% | -4.2% | -3.1% | -0.1% | -10.3% | -7.8% |
| — | +109.5% | +149.3% | -39.8% | +0.6% | -184.5% | -222.4% | +63.7% | -166.2% | -7.9% | -1229.8% | -95.3% | +18.6% | +13.8% | +134.8% | +3.1% | +45.3% | +94.7% | +96.1% | +16.5% | -146.6% | |
| Net Margin | -6.8% | 1.2% | 2.1% | -12.0% | -7.7% | -7.5% | 0.8% | -6.9% | -8.1% | -2.1% | -0.4% | -28.3% | -2.8% | -1.6% | 1.5% | -8.2% | -4.4% | -3.1% | 0.2% | -12.3% | -7.8% |
| — | +116.1% | +167.0% | -73.2% | +5.3% | -261.6% | +309.0% | +75.4% | -193.2% | -32.1% | -124.9% | -245.2% | +37.3% | +49.2% | +707.5% | +33.2% | +43.5% | +94.9% | +105.2% | -62.4% | -106.6% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -135.6% | 8.8% | 19.5% | -87.3% | -30.8% | -23.0% | 2.5% | -20.2% | -18.8% | -4.5% | -0.9% | -30.1% | -3.6% | -1.7% | 1.5% | -5.3% | -2.8% | -1.9% | 0.1% | -5.1% | -3.1% |
| — | +138.2% | +679.9% | -331.4% | -63.9% | -410.5% | +377.5% | +32.7% | -423.8% | -163.3% | -159.5% | -466.1% | -28.1% | +8.4% | +1251.7% | -3.9% | +11.0% | +97.3% | — | — | — | |
| ROA | -27.0% | 1.2% | 2.2% | -13.2% | -6.7% | -5.7% | 0.7% | -5.5% | -5.5% | -1.4% | -0.3% | -11.5% | -1.4% | -0.7% | 0.8% | -3.2% | -1.7% | -1.1% | 0.1% | -3.5% | -2.1% |
| — | +120.3% | +226.9% | -138.2% | -20.5% | -318.0% | +321.0% | +51.8% | -307.2% | -85.0% | -136.1% | -262.3% | +17.9% | +33.7% | +1058.7% | +8.7% | +21.9% | +95.7% | +102.4% | +36.1% | — | |
| ROIC | -203.2% | 7.7% | 23.4% | -144.8% | -43.7% | -25.5% | -4.6% | -20.6% | -18.7% | -5.3% | -0.9% | -17.7% | -3.9% | -2.9% | 0.0% | -8.5% | -4.1% | -5.0% | -0.5% | -38.9% | -31.8% |
| — | +130.3% | +612.4% | -601.9% | -133.7% | -379.9% | -417.2% | -16.7% | -374.2% | -81.0% | -2036.1% | -107.5% | +3.7% | +40.8% | +109.9% | +78.1% | +87.1% | +98.2% | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.15 | 0.18 | 0.29 | 0.12 | 0.10 | 0.08 | 0.09 | 0.08 | 0.07 | 0.07 | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| — | +45.3% | +119.2% | +211.2% | +58.8% | +48.1% | +20.6% | +18.0% | +28.6% | +17.9% | +42.9% | +56.6% | +17.2% | +12.2% | -2.3% | -7.5% | +0.5% | +8.1% | — | — | — | |
| Debt / EBITDA | — | 1.79 | 1.98 | — | — | — | — | — | — | — | — | — | — | — | 11.45 | — | — | — | 21.08 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | -45.7% | — | — | — | — | — | — | |
| Current Ratio | 1.02 | 1.08 | 1.04 | 1.02 | 1.08 | 1.16 | 1.20 | 1.27 | 1.29 | 1.36 | 1.33 | 1.51 | 1.50 | 1.50 | 1.93 | 2.71 | 2.48 | 2.65 | 2.67 | 3.83 | 3.44 |
| — | -7.1% | -13.5% | -19.5% | -16.1% | -14.4% | -10.0% | -16.5% | -14.5% | -9.5% | -30.8% | -44.2% | -39.4% | -43.3% | -27.7% | -29.2% | -27.7% | -26.3% | +137.6% | +247.4% | — | |
| Quick Ratio | 1.02 | 1.08 | 1.04 | 1.02 | 1.08 | 1.16 | 1.20 | 1.27 | 1.29 | 1.36 | 1.33 | 1.51 | 1.50 | 1.50 | 1.93 | 2.71 | 2.48 | 2.65 | 2.67 | 3.83 | 3.44 |
| — | -7.1% | -13.5% | -19.5% | -16.1% | -14.4% | -10.0% | -16.5% | -14.5% | -9.5% | -30.8% | -44.2% | -39.4% | -43.3% | -27.7% | -29.2% | -27.7% | -26.3% | +137.6% | +247.4% | — | |
| Interest Coverage | -59.85 | 2.71 | 15.53 | -108.30 | -59.14 | -65.35 | -0.12 | -65.50 | -71.15 | -16.82 | 3.43 | -85.25 | -11.88 | -8.62 | 6.49 | -31.73 | -28.94 | -20.65 | 1.75 | -67.15 | -41.37 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 26 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AGL stock.
Agilon Health, Inc.'s current P/E is -3.4x. The average P/E over the last 2 quarters is 13.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Agilon Health, Inc.'s current operating margin is -7.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Agilon Health, Inc.'s business trajectory between earnings reports.